Clinical Trial Update: Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on cell therapy using Cellistem-OA for knee osteoarthritis across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Cell Therapy
• Cellistem-OA
• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | Conditions: Mesenchymal Stem Cells, Knee Osteoarthritis | Phase 1, Phase 2 | Status: UNKNOWN